Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.

AIDS (London, England) - 4 Nov 2005

Palmisano Lucia, Giuliano Marina, Nicastri Emanuele, Pirillo Maria Franca, Andreotti Mauro, Galluzzo Clementina M, Bucciardini Raffaella, Fragola Vincenzo, Andreoni Massimo, Vella Stefano

Abstract excerpt

OBJECTIVE: To determine factors associated with < 2.5 copies/ml plasma HIV RNA in subjects treated with highly active antiretroviral therapy (HAART) and with viraemia < 50 copies/ml. DESIGN: Cross-sectional analysis of 84 HIV-positive patients taking HAART with plasma HIV RNA < 50 copies/ml for at least 6 months and no history of virological failure. METHODS: Current HAART therapy was based on a non-nucleoside...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chronic Disease

Share to DNA, Viral

Share to Leukocytes, Mononuclear

Share to Regression Analysis

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 16227792
DOI: 10.1097/01.aids.0000188426.87538.ed

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Residual viraemia in subjects with chronic HIV infection and viral load < 50 copies/ml: the impact of highly active antiretroviral therapy.PMID 16227792Read ↗

HIV-1 persistence during ARTSemantic proximity Read ↗

Persistent low-Level viremia in persons living with HIV undertreatment: An unresolved status.Semantic proximity Read ↗

Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients.Semantic proximity Read ↗

Impact of pre-therapy viral load on virological response to modern first-line HAART.Semantic proximity Read ↗

Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 <sup>+</sup> T CellsSemantic proximity Read ↗

High serum HCV RNA in chronic hepatitis C patients coinfected with HIV despite successful antiretroviral therapy.Semantic proximity Read ↗

Residual Viremia in Treated HIV+ IndividualsSemantic proximity Read ↗

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 InfectionSemantic proximity Read ↗

Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.Semantic proximity Read ↗

HIV-1 RNA and HIV-1 DNA persistence during suppressive ART with PI-based or nevirapine-based regimensSemantic proximity Read ↗

Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment.Semantic proximity Read ↗

Residual human immunodeficiency virus type 1 infection in lymphoid tissue during highly active antiretroviral therapy: quantitation and virus characterization.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.